Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yerong Yu

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
The Lancet. Diabetes & Endocrinology|October 17, 2017
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trialAndré Lacroix, Feng Gu, Wilson Gallardo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2022
Randomized Trial of Osilodrostat for the Treatment of Cushing DiseaseMônica Gadelha, Marie Bex, Richard A Feelders, et al.
Trials|June 21, 2025
Postoperative Initiation of Thromboprophylaxis in patients with Cushing's Disease (PIT-CD): a randomized controlled trialNidan Qiao, Min He, Zhao Ye, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
The Lancet. Diabetes & Endocrinology|October 17, 2017
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trialAndré Lacroix, Feng Gu, Wilson Gallardo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2022
Randomized Trial of Osilodrostat for the Treatment of Cushing DiseaseMônica Gadelha, Marie Bex, Richard A Feelders, et al.
Trials|June 21, 2025
Postoperative Initiation of Thromboprophylaxis in patients with Cushing's Disease (PIT-CD): a randomized controlled trialNidan Qiao, Min He, Zhao Ye, et al.
Pageof 8